Prevalence, risk factors, and impact of long COVID in a socially vulnerable community in Brazil: a prospective cohort study, Azambuja et al., 2024

Discussion in 'Long Covid research' started by Nightsong, Jul 19, 2024 at 8:14 PM.

  1. Nightsong

    Nightsong Senior Member (Voting Rights)

    Messages:
    270
    Prevalence, risk factors, and impact of long COVID in a socially vulnerable community in Brazil: a prospective cohort study

    Summary
    Background

    Long COVID is an emerging global public health issue. Socially vulnerable communities in low- and-middle-income countries were severely impacted by the pandemic and are underrepresented in research. This prospective study aimed to determine the prevalence of long COVID, its impact on health, and associated risk factors in one such community in Rio de Janeiro, Brazil.

    Methods
    A total of 710 individuals aged 18 and older, with confirmed SARS-CoV-2 infection at least three months prior, were enrolled between November 25, 2021, and May 5, 2022. Participants were assessed via telephone or in person using a standardized questionnaire to evaluate their perception of recovery, symptoms, quality of life, and functional status.

    Findings
    Twenty percent of participants did not feel fully recovered, 22% experienced new or persistent symptoms, 26% had worsened functional status, 18% had increased dyspnoea, and 32% reported a worse quality of life. Persistent symptoms included headache, cough, fatigue, muscle pain, and shortness of breath. Dyspnoea during the acute phase was the strongest independent predictor of worsening outcomes. Females and individuals with comorbidities were more likely to report worse recovery, functioning, dyspnoea, and quality of life.

    Interpretation
    Our findings reveal a high burden of severe and persistent physical and mental health sequelae in a socially vulnerable community following COVID-19.

    Funding
    UK Foreign, Commonwealth and Development Office and Wellcome Trust Grant (222048/Z/20/Z), Fundação Oswaldo Cruz (FIOCRUZ), Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ), and the Centers for Disease Control and Prevention(CDC).

    The Lancet Regional Health (Americas) | Open Access | Link
     
    Peter Trewhitt, Sean and shak8 like this.

Share This Page